REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Medan Jaya Pharmacy Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Medan Jaya Pharmacy Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Medan Jaya Pharmacy Sdn. Bhd. is a company in Malaysia, with a head office in Bintulu. The company operates in the Pharmacies and Drug Stores sector. The company was established on December 11, 2013. The company’s latest financial report indicates a net sales revenue drop of 25.27% in 2023. Over the same period, its total assets decreased by 2.76%. In 2023, Medan Jaya Pharmacy Sdn. Bhd.’s net profit margin decreased by 3.48%.

Headquarters
No.45-46, Ground Floor, Medan Jaya Commercial Centre, Jalan Tun Hussein Onn
Bintulu; Sarawak; Postal Code: 97000

Contact Details: Purchase the Medan Jaya Pharmacy Sdn. Bhd. report to view the information.

Basic Information
Registered Capital:
Purchase the Medan Jaya Pharmacy Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Medan Jaya Pharmacy Sdn. Bhd. report to view the information.
Incorporation Date:
December 11, 2013
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Medan Jaya Pharmacy Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-25.27%▼
Total operating revenue
-25.27%▼
Operating profit (EBIT)
-43.97%▼
EBITDA
-44.68%▼
Net Profit (Loss) for the Period
-43.4%▼
Total Assets
-2.76%▼
Total Equity
9.61%▲
Operating Profit Margin (ROS)
-4.38%▼
Net Profit Margin
-3.48%▼
Return on Equity (ROE)
-44.58%▼
Quick Ratio
0.56%▲
Cash Ratio
0.17%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo